On April 11, 2025, Democratic Representative Scott Franklin from Florida's 18th district disclosed two significant stock transactions involving Novo Nordisk A/S Common Stock (NVO). On March 27, 2025, Rep. Franklin made two separate purchases of NVO shares. The first transaction involved acquiring shares valued between $1,001 and $15,000. On the same day, he executed a second purchase of NVO shares, with the transaction amount ranging from $15,001 to $50,000. These trades indicate a strategic investment in Novo Nordisk, suggesting Rep. Franklin's interest or confidence in the company's potential performance in the market.